BRAF and melanoma: According to the TCGA data analysis, TERT promoter mutations frequently occur in melanoma, mainly in the BRAF (75% of cases), RAS (72% of cases), and NF1 (83% of cases) subtypes [36], suggesting a link between MAPK activation and TERT expression.